Vexim – About the Company

vexim
Vexim (NYSE Alternext Paris: ALVXM.PA) is a commercial-stage company that markets SpineJack®, a minimally invasive solution for the treatment of vertebral compression fractures (VCFs). The product is CE marked and being sold through a direct sales force in leading European markets and through distributors internationally. Sales have nearly doubled each quarter year over year for eight consecutive quarters. Vexim plans to conduct clinical studies to expand the commercial reach of SpineJack® and related products in the US.